Clinical features and prognosis of boston type I keratoprosthesis- associated corneal melt

Ocular Immunology and Inflammation

Volumn 19, Issue 6, 2011, Pages 413-418

  Utine, Canan Asli ^a,b   Tzu, Jonathan H ^a   Akpek, Esen K ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Boston keratoprosthesis; corneal melt; Sj gren's syndrome; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CORNEA DISEASE; CORNEA MELT; CORNEA TRANSPLANTATION; ENDOPHTHALMITIS; EXPLANT; FEMALE; HUMAN; KERATITIS; KERATOMYCOSIS; KERATOPROSTHESIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SJOEGREN SYNDROME;

AGED; AGED, 80 AND OVER; ARTIFICIAL ORGANS; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 81855193719     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.621580     Document Type: Article

References (22)

1. Zerbe BL, Belin MW, Cioliono JB, et al. Results from the multicenter Boston Type I Keratoprosthesis Study. Ophthalmology. 2006;113(10):1779-1784.
2. Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640-651.
3. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28(9):989-996.
4. Bradley JC, Hernandez EG, Schwab IR, et al. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea. 2009;28(3):321-327.
5. Khan BF, Harissi-Dagher M, Khan DM, et al. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin. 2007;47(2):61-71.
6. Dohlman CH, Dudenhoefer EJ, Khan BF, et al. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28(2):72-74.
7. Hicks CR, Crawford GJ. Melting after keratoprosthesis implantation: the effects of medroxyprogesterone. Cornea. 2003;22(6):497-500.
8. Sayegh RR, Ang LPK, Foster S, et al. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol. 2008;145(3):438-444.
9. Dohlman CH, Abad JC, Dudenhoefer EJ, et al. Keratoprosthesis: beyond corneal graft failure. In: Spaeth G, ed. Ophthalmic Surgery: Principles and Practice. Philadelphia: WB Saunders; 2003: 199-207.
10. Brown SI, Dohlman CH. A buried corneal implant serving as a barrier to fluid. Arch Ophthalmol. 1965;73(5):635-639.
11. Riley MV. Glucose and oxygen utilization by the rabbit cornea. Exp Eye Res. 1969;8(2):193-200.
12. Klyce SD Corneal physiology. In: Foster CS, Azar D, Dohlman CH, eds. Smolin and Thoft's The Cornea, 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2004: 635-639.
13. L ucarelli MJ, Dartt DA, Cook BE, et al. The lacrimal system. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye, Clinical Application, 10th ed. St. Louis, MO: CV Mosby; 2003: 30-43.
14. Turss R, Friend J, Dohlman CH. Effect of a corneal barrier on the nutrition of the epithelium. Exp Eye Res. 1970;9(2): 254-259.
15. McCarey BE. Refractive keratoplasty with synthetic lens implants. Int Ophthalmol Clin. 1991;31(1):87-99.
16. Harissi-Dagher M, Khan BF, Schaumberg DA, et al. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea. 2007;26(5): 564-568.
17. Dudenhoefer EJ, Nouri M, Gipson IK, et al. Histopathology of explanted collar button keratoprostheses: a clinicopathologic correlation. Cornea. 2003;22(5):424-428.
18. Ciralsky J, Papaliodis GN, Foster CS, et al. Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm. 2010;18(4): 275-280.
19. Coassin M, Zhang C, Green WR, et al. Histopathologic and immunologic aspects of AlphaCor artificial corneal failure. Am J Ophthalmol. 2007;144(5):699-704.
20. Zhu S, Dekaris I, Duncker M, et al. Early expression of roinflammatory cytokines interleukin-1 and tumor necrosis factor- alpha after corneal transplantation. J Interferon Cytokine Res. 1999;19(6):661-669.
21. Dohlman CH, Doane MG. Some factors influencing outcome after keratoprosthesis surgery. Cornea. 1994;13(3):214-218.
22. Tay E, Utine CA, Akpek EK. Crescenteric amniotic membrane grafting in keratoprosthesis-associated corneal melt. Arch Ophthalmol. 2010;128(6):779-782.